Georgia Tech's Bio-impact Commercialization Team (BCT)
The BCT is a focused, institutional commitment to translational research in biomedicine. A team with expertise in the bio-medical device space will work closely with faculty members and the venture capital community to facilitate translational research and commercialization. This team is part of a larger effort to unify work at Georgia Tech and various healthcare strategic partners.